欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4372/005
药品名称Methotrexate Mylan
活性成分
    • methotrexate 15.0 mg
剂型-
上市许可持有人Mylan S.A.S. 117 Allee Des Parcs St Priest Rhone, France
参考成员国 - 产品名称Netherlands (NL)
Methotrexaat Mylan
互认成员国 - 产品名称
    • Czechia (CZ)
      Methotrexate Mylan 15 mg
    • Greece (GR)
    • Cyprus (CY)
      Methotrexate 15mg solution for injection 37,5mg/ml
    • Portugal (PT)
    • Romania (RO)
      Methotrexat Mylan 15 mg, soluție injectabilă 37.5 mg/ml
    • Poland (PL)
    • Italy (IT)
许可日期2019/03/12
最近更新日期2019/07/29
药物ATC编码
    • L04AX03 methotrexate
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase